Repurposing Lithium for Parkinson's Disease

Completed · Phase 1

Conditions studied: Parkinson's Disease

In brief

This study will examine the effects of lithium aspartate 30-45mg/day on MRI biomarkers and blood-based therapeutic targets among 15 early-stage Parkinson's disease patients.

Key facts

Study ID
NCT06099886
Run by
State University of New York at Buffalo
People needed
15
Starts
2023-10-12
Expected to finish
2025-04-30
Last updated by the study team
2026-05-13

Who can join

Age: 45 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.